The dysregulation of TERC expression in oncogenesis may be attributable to different mechanisms, including aberrant alterations in transcriptional and epigenetic statuses, oncogenic signalling activation, gene amplification and among others, which depend on cancer types.3 The gene discussed is TERC; the disease is cancer.